<DOC>
	<DOCNO>NCT00246584</DOCNO>
	<brief_summary>This study evaluate safety efficacy long term treatment SPP100 patient essential hypertension . ( Trial recruit US )</brief_summary>
	<brief_title>A Long Term Study SPP100 Patients With Essential Hypertension ( Trial Not Recruiting US )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Diagnosed essential hypertension Patients secondary hypertension suspect secondary hypertension . Patients suspect malignant hypertension Patients serious disease symptom</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>angiotensin</keyword>
	<keyword>renin</keyword>
	<keyword>aliskiren</keyword>
</DOC>